Molecular Genetic Testing

Solutions by Sequence Inc. (SBS) is a world-leading private Canadian corporation that designs and conducts genetic diagnostic tests. In close parternship with clinical specialists, the reference labs created by SBS identify members of a family who carry a genetic predisposition to disease. This improves the quality of care for the entire family, while reducing overall costs by sparing those who do not have the disease from expensive and invasive clinical surveillance.

SBS has developed genetic reference labs that identify mutations for three diseases:

SBS sees an exceptional opportunity to take molecular diagnosis from research labs to clinical application. The value of this expertise can be multiplied by applying it to the knowledge of many experts in genetic disease.

There are currently few players in the market for complex, specialized, high-impact genetic tests.

The great value of SBS methods derives from a disease-specific focus with rigorous optimization to achieve the highest possible test sensitivity. This unique approach leads to profound consequences by (a) removing half or more of the patients at risk from costly surveillance, (b) increasing the quality of life by reducing uncertainty about carrier status, and (c) freeing health care resources for application to those who are truly at risk of disease.